电话:
+86 (0512) 65829739
传真:
+86 (010) 6788 5057
电子邮件:
orders@antibodies-online.cn

STK33 抗体

(serine/threonine Kinase 33 (STK33))
Serine/threonine protein kinase which phosphorylates VIME. May play a specific role in the dynamic behavior of the intermediate filament cytoskeleton by phosphorylation of VIME (By similarity).
STK33 抗体  (AA 1-514) STK33 抗体  (AA 1-514) STK33 抗体 (AA 1-514) (ABIN566314)

STK33 适用: 人 WB, ELISA, IF, IP 宿主: 小鼠 Monoclonal 1F10 unconjugated

STK33 抗体  (AA 1-514) STK33 抗体  (AA 1-514) STK33 抗体 (AA 1-514) (ABIN566310)

STK33 适用: 人 WB, ELISA, IF, IP, RNAi 宿主: 小鼠 Monoclonal 6G1 unconjugated

STK33 抗体  (AA 1-514) STK33 抗体  (AA 1-514) STK33 抗体 (AA 1-514) (ABIN566312)

STK33 适用: 人 WB, ELISA, IP 宿主: 小鼠 Monoclonal 4F7 unconjugated

STK33 抗体 by 适用

Find STK33 抗体 for a variety of species such as anti-Human STK33, anti-Mouse STK33, anti-Rat STK33. The species listed below are among those available. Click on a link to go to the corresponding products.

STK33 抗体 by 应用范围

Find STK33 抗体 validated for a specific application such as WB, ELISA, IF (cc), IF (p). Some of the available applications are listed below. Click on a link to go to the corresponding products.

STK33 抗体 by 抗体来源

Find STK33 抗体 with a specific 抗体来源. The 抗体来源 listed below are among those available. Click on a link to go to the corresponding products.

STK33 抗体 by 抗原表位

Find STK33 抗体 with a specific epitope. The epitopes listed below are among those available. Click on a link to go to the corresponding products.

STK33 抗体 by 克隆形成能力

Find available monoclonal or polyclonal STK33 抗体. Click on a link to go to the corresponding products.

STK33 抗体 by 克隆

Find STK33 抗体 with a specific 克隆. The 克隆 listed below are among those available. Click on a link to go to the corresponding products.

STK33 抗体 by 标记

Find STK33 抗体 with a specific conjugate such as FITC, APC, Biotin. The conjugates listed below are among those available. Click on a link to go to the corresponding products.

Popular STK33 抗体

Product
Reactivity
Application
Validations
Cat. No.
Quantity
Datasheet
Reactivity Human
Application WB, ELISA, IF, IP
Validations
  • (2)
  • (8)
Cat. No. ABIN566314
Quantity 100 μg
Datasheet Datasheet
Reactivity Human
Application WB, ELISA, IF, IP, RNAi
Validations
  • (1)
  • (7)
Cat. No. ABIN566310
Quantity 100 μg
Datasheet Datasheet
Reactivity Human
Application WB, ELISA, IP
Validations
  • (2)
  • (5)
Cat. No. ABIN566312
Quantity 50 μg
Datasheet Datasheet
Reactivity Human
Application WB, ELISA, IF, IP
Validations
  • (5)
Cat. No. ABIN566311
Quantity 100 μg
Datasheet Datasheet
Reactivity Human
Application WB, ELISA, IHC (p), IF
Validations
  • (5)
Cat. No. ABIN566313
Quantity 100 μg
Datasheet Datasheet
Reactivity Human
Application WB, ELISA, IHC, IF
Validations
  • (3)
Cat. No. ABIN7168993
Quantity 100 μg
Datasheet Datasheet
Reactivity Human
Application WB, ELISA, IHC, IF, ICC
Validations
  • (3)
Cat. No. ABIN6259201
Quantity 100 μL
Datasheet Datasheet
Reactivity Human
Application WB, ELISA, IHC, IHC (p), IF
Validations
  • (3)
Cat. No. ABIN574460
Quantity 50 μg
Datasheet Datasheet
Reactivity Human
Application WB, ELISA, IHC
Validations
  • (2)
Cat. No. ABIN7189024
Quantity 100 μg
Datasheet Datasheet
Reactivity Human
Application WB, IP
Validations
  • (2)
Cat. No. ABIN949614
Quantity 100 μL
Datasheet Datasheet
Reactivity Human
Application WB
Validations
  • (2)
Cat. No. ABIN528802
Quantity 50 μg
Datasheet Datasheet
Reactivity Human
Application WB, IHC, IHC (p)
Validations
  • (2)
Cat. No. ABIN6749787
Quantity 100 μL
Datasheet Datasheet
Reactivity Human
Application WB, IF
Validations
  • (2)
Cat. No. ABIN7270224
Quantity 100 μL
Datasheet Datasheet
Reactivity Human
Application WB, ELISA
Validations
  • (1)
Cat. No. ABIN7184507
Quantity 100 μL
Datasheet Datasheet
Reactivity Human
Application WB
Validations
  • (1)
Cat. No. ABIN2854508
Quantity 100 μL
Datasheet Datasheet

Latest Publications for our STK33 抗体

Azoitei, Hoffmann, Ellegast, Ball, Obermayer, Gößele, Koch, Faber, Genze, Schrader, Kestler, Döhner, Chiosis, Glimm, Fröhling, Scholl: "Targeting of KRAS mutant tumors by HSP90 inhibitors involves degradation of STK33." in: The Journal of experimental medicine, Vol. 209, Issue 4, pp. 697-711, (2012) (PubMed).

Babij, Zhang, Kurzeja, Munzli, Shehabeldin, Fernando, Quon, Kassner, Ruefli-Brasse, Watson, Fajardo, Jackson, Zondlo, Sun, Ellison, Plewa, San, Robinson, McCarter, Schwandner, Judd, Carnahan, Dussault: "STK33 kinase activity is nonessential in KRAS-dependent cancer cells." in: Cancer research, Vol. 71, Issue 17, pp. 5818-26, (2011) (PubMed).

Scholl, Fröhling, Dunn, Schinzel, Barbie, Kim, Silver, Tamayo, Wadlow, Ramaswamy, Döhner, Bullinger, Sandy, Boehm, Root, Jacks, Hahn, Gilliland: "Synthetic lethal interaction between oncogenic KRAS dependency and STK33 suppression in human cancer cells." in: Cell, Vol. 137, Issue 5, pp. 821-34, (2009) (PubMed).

Cantrell: "Phosphoinositide 3-kinase signalling pathways." in: Journal of cell science, Vol. 114, Issue Pt 8, pp. 1439-45, (2001) (PubMed).

Blume-Jensen, Hunter: "Oncogenic kinase signalling." in: Nature, Vol. 411, Issue 6835, pp. 355-65, (2001) (PubMed).

Jhiang: "The RET proto-oncogene in human cancers." in: Oncogene, Vol. 19, Issue 49, pp. 5590-7, (2000) (PubMed).

Aliases for STK33 抗体

serine/threonine kinase 33 (STK33) 抗体
serine/threonine kinase 33 (Stk33) 抗体
4921505G21Rik 抗体
AW061264 抗体
You are here:
客服